Astrea

Nuvve Provides Third Quarter 2023 Financial Update

Retrieved on: 
Thursday, November 9, 2023
Sale, EPA, Astrea, Baozou Big News Events, Engineering, SAN, Insurance, Research, Marketing, Advertising, AC, VIE, Partnership, Forecasting, Total, Growth, EV, Bluebird, Satellite navigation device, Renewable energy, Life insurance, Nuvve Kavali

SAN DIEGO, Nov. 9, 2023 /PRNewswire/ -- Nuvve Holding Corp. (Nuvve) (Nasdaq: NVVE), a green energy technology company that provides a globally-available, commercial vehicle-to-grid (V2G) technology platform that enables electric vehicle (EV) batteries to store and resell unused energy back to the local electric grid and provides other grid services, today provided a third quarter 2023 update. 

Key Points: 
  • SAN DIEGO, Nov. 9, 2023 /PRNewswire/ -- Nuvve Holding Corp. (Nuvve) (Nasdaq: NVVE), a green energy technology company that provides a globally-available, commercial vehicle-to-grid (V2G) technology platform that enables electric vehicle (EV) batteries to store and resell unused energy back to the local electric grid and provides other grid services, today provided a third quarter 2023 update.
  • Products and services margin decreased to 9.0% for the three months ended September 30, 2023, compared to 43.3% in the same prior year period.
  • In each of the three months ended September 30, 2023 and 2022, we recorded no material income tax expenses.
  • The Company will hold a conference call to review its financial results for the third quarter of 2023, along with other Company developments, at 5:00 PM Eastern Time (2:00 PM PT) today, Thursday, November 9, 2023.

Nuvve Provides Second Quarter 2023 Financial Update

Retrieved on: 
Thursday, August 10, 2023
Insurance, Advertising, Optimism, Travel, EV, Marketing, DC, VIE, Astrea, AC, SAN, Engineering, Transport, Research, Total, Cryptocurrency, Life insurance, Nuvve Kavali

SAN DIEGO, Aug. 10, 2023 /PRNewswire/ -- Nuvve Holding Corp. (Nuvve) (Nasdaq: NVVE), a green energy technology company that provides a globally-available, commercial vehicle-to-grid (V2G) technology platform that enables electric vehicle (EV) batteries to store and resell unused energy back to the local electric grid and provides other grid services, today provided a second quarter 2023 update. 

Key Points: 
  • SAN DIEGO, Aug. 10, 2023 /PRNewswire/ -- Nuvve Holding Corp. (Nuvve) (Nasdaq: NVVE), a green energy technology company that provides a globally-available, commercial vehicle-to-grid (V2G) technology platform that enables electric vehicle (EV) batteries to store and resell unused energy back to the local electric grid and provides other grid services, today provided a second quarter 2023 update.
  • Overall, visibility is gradually improving, and we expect to sustain momentum from the first half of the year in the second half."
  • Products and services margin increased to 4.8% for the three months ended June 30, 2023 compared to 3.1% in the same prior year period.
  • The Company will hold a conference call to review its financial results for the second quarter of 2023, along with other Company developments, at 5:00 PM Eastern Time (2:00 PM PT) today, Thursday, August 10, 2023.

A Young Boy's Last Hope: FHD Forensics' Unique Collaboration Aims to Bring Closure to Three Florida Cold Cases

Retrieved on: 
Thursday, July 13, 2023
DNA, Hair, Justice, FHD, Burial, Genealogy, Astrea, Love, Ageing, Family, News, Drug, Private investigator, Nightclub, Dean, PayPal

FHD Forensics is happy to announce a new collaboration with the Volusia County, Florida Sheriff's Office on three cold cases driven by the desire of the families of Dean and Tina Linn Clouse to help solve cases in their own backyard.

Key Points: 
  • FHD Forensics is happy to announce a new collaboration with the Volusia County, Florida Sheriff's Office on three cold cases driven by the desire of the families of Dean and Tina Linn Clouse to help solve cases in their own backyard.
  • The young couple went unidentified for four decades after being found murdered near Houston, Texas in 1981.
  • Genetic genealogy identified them in 2021, putting an end to decades of longing for news on the part of their families.
  • Links can also be found on the websites for Genealogy For Justice and FHD Forensics to donate via Paypal .

Nuvve Introduces Astrea AI Forecasting for Nordic Energy Market

Retrieved on: 
Thursday, June 22, 2023
Nuvve Nuvve, Ancillary services (electric power), Generator, ISO, V2G, Power, Electricity, Distributed generation, Intelligence, Astrea, Forecasting, FERC, SAN, Bundesverband der Energie- und Wasserwirtschaft, Renewable energy, EU, Nordic

Astrea AI continuously forecasts prices and capacity for Nordic primary reserves to optimize energy market bids.

Key Points: 
  • Astrea AI continuously forecasts prices and capacity for Nordic primary reserves to optimize energy market bids.
  • Astrea AI technology is integrated with Nuvve's GIVe™ platform for V2G and charge management and will automate future bidding and frequency regulation market selection.
  • Nuvve formed Astrea AI in early 2022 to provide improved forecasting, a worldwide tariff database, predictive maintenance and energy insights and reporting, among other benefits, thereby strengthening its GIVe™ technology even further.
  • Astrea AI makes energy markets easier and more accurate to predict, enabling us to further optimize revenue from our market participation.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

Retrieved on: 
Thursday, September 29, 2022
Oncology, Health, Genetics, Health Technology, Pharmaceutical, Biotechnology, Lentivirus, Therapy, Â, Technology, LVV, Efficiency, FDA, Bioseparation of 1,3-propanediol, Nereus, Astrea, Fine chemical, Medical device

Astrea Bioseparations (Astrea Bio), a leading provider of novel purification and separation tools supporting the development of next-generation therapeutics, has announced today the commercial launch of its Nereus LentiHERO lentiviral vector (LVV) purification technology.

Key Points: 
  • Astrea Bioseparations (Astrea Bio), a leading provider of novel purification and separation tools supporting the development of next-generation therapeutics, has announced today the commercial launch of its Nereus LentiHERO lentiviral vector (LVV) purification technology.
  • We believe that AstreAdept will be a game-changer, explained Astrea Bioseparations CEO Terry Pizzie.
  • Astrea Bio has been developing purification and separation technologies for more than 30 years, with several products used to manufacture FDA approved treatments.
  • For further information about Astrea Bioseparations, please visit: https://www.astreabioseparations.com/
    View source version on businesswire.com: https://www.businesswire.com/news/home/20220929005700/en/

Livestock Feeding Robots Market to Record an Exponential CAGR by 2030 - Exclusive Report by InsightAce Analytic

Retrieved on: 
Wednesday, July 13, 2022
Technology, Milk, Cattle, AMI, AGCO, Dairy, Galaxy, Fertility, Adoption, Health, Knowledge, Robotics, Weather, Merlin, Manure, HMC, Ruminant, Automation, CAGR, Efficiency, Horse, Farmer, Poultry, Astrea, GEA, Acquisition, Food, JOZ, CRD, Small, Research, Feed manufacturing, Agriculture, Valmet, Livestock, Domestic pig

According to the latest research by InsightAce Analytic, the global livestock feeding robots market is expected to exhibit a CAGR of 8.79% during the forecast period of 2022-2030.

Key Points: 
  • According to the latest research by InsightAce Analytic, the global livestock feeding robots market is expected to exhibit a CAGR of 8.79% during the forecast period of 2022-2030.
  • The use of livestock feeding robots enables individualised dietary demands for each animal.
  • These aspects have contributed to the market for livestock feeding robots in North America.
  • Global Livestock Feeding Robots Market, by Livestock, 2022-2030 (Value US$ Mn)

Livestock Feeding Robots Market to Record an Exponential CAGR by 2030 - Exclusive Report by InsightAce Analytic

Retrieved on: 
Wednesday, July 13, 2022
Technology, Milk, Cattle, AMI, AGCO, Dairy, Galaxy, Fertility, Adoption, Health, Knowledge, Robotics, Weather, Merlin, Manure, HMC, Ruminant, Automation, CAGR, Efficiency, Horse, Farmer, Poultry, Astrea, GEA, Acquisition, Food, JOZ, CRD, Small, Research, Feed manufacturing, Agriculture, Valmet, Livestock, Domestic pig

According to the latest research by InsightAce Analytic, the global livestock feeding robots market is expected to exhibit a CAGR of 8.79% during the forecast period of 2022-2030.

Key Points: 
  • According to the latest research by InsightAce Analytic, the global livestock feeding robots market is expected to exhibit a CAGR of 8.79% during the forecast period of 2022-2030.
  • The use of livestock feeding robots enables individualised dietary demands for each animal.
  • These aspects have contributed to the market for livestock feeding robots in North America.
  • Global Livestock Feeding Robots Market, by Livestock, 2022-2030 (Value US$ Mn)

Moore Kuehn Encourages VEI, IEC, XONE, and ASAX Investors to Contact Law Firm

Retrieved on: 
Tuesday, August 31, 2021
Telephone, Creation Technologies, Electronics, Desktop Metal, Chesapeake Energy, Wall Street, Fraud, Google, PLLC, Board, Astrea, IEC Electronics, Exon, Security (finance), Bank

Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies:

Key Points: 
  • Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies:
    Vine Energy has agreed to merge with Chesapeake Energy.
  • Under the proposed transaction, Vine Energy shareholders will receive 0.2486 shares of Chesapeake Energy per share and $1.20 in cash per share.
  • Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq.
  • Moore Kuehn is a 5-star Google client-rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims.

Avacta Group plc Signs License Agreement With Astrea Bioseparations

Retrieved on: 
Monday, December 21, 2020
Biotechnology, Health, Pharmaceutical, Clinical trials, Oncology, Affimer, Astrea, Aerial Support to Regional Enforcement Agencies, Affinity chromatography, License

Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms, is pleased to announce that it has entered into a license agreement with Astrea Bioseparations (Astrea) for the use of the Affimer platform in affinity purification applications.

Key Points: 
  • Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms, is pleased to announce that it has entered into a license agreement with Astrea Bioseparations (Astrea) for the use of the Affimer platform in affinity purification applications.
  • Following Astreas successful evaluation of Affimer reagents for affinity separation, the two companies have entered into a non-exclusive license agreement for the use of the Affimer technology in this field.
  • The agreement includes a 0.5 million upfront payment to Avacta which gives Astrea the rights to generate and develop Affimer reagents in-house for affinity separation.
  • Dr Alastair Smith, Chief Executive Officer of Avacta Group, commented: I am delighted to have entered into this license agreement with Astrea following their evaluation of the Affimer platform.

Gamma Biosciences Announces Strategic Licensing Agreement by Astrea Bioseparations for Advanced Application of Avacta Affimer® Reagent Technology

Retrieved on: 
Monday, December 21, 2020
Affimer, Branches of biology, Biotechnology, Biology, Life sciences, Immunology, Antibody, Astrea, Bioprocess

The licensing agreement gives Astrea access to the Affimer technology for applications in bioprocessing, expanding its range of ligand discovery and development capabilities to include best-in-class chemical and biological platforms for customer development programs.

Key Points: 
  • The licensing agreement gives Astrea access to the Affimer technology for applications in bioprocessing, expanding its range of ligand discovery and development capabilities to include best-in-class chemical and biological platforms for customer development programs.
  • "Affimer reagents are high-performance proteinaceous ligands that have been engineered for a wide range of applications as superior alternatives to antibody-based ligands.
  • The license agreement includes an option that gives Astrea the ability to secure exclusive access to the Affimer technology for applications in bioprocessing.
  • The Astrea Bioseparations team expects to begin development of new products based on the technology early in 2021.